StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BPTH

Bio-Path Holdings, Inc.

BPTH OTC Pharmaceutical Preparations EDGAR ↗
$0.04
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$2.01M
Revenue (TTM)
$37.0K
Net income (TTM)
-$8.70M
EPS (TTM)
$-1.09
P/E ratio
Dividend yield
Free cash flow
-$10.6M
Cash
$12.0K
Total assets
$677K
Gross margin
52-week range
$0.01 – $0.14

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure; Other events Jul 16, 2026 8-K Regulation FD disclosure; Other events May 26, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 8-K Amended charter or bylaws; Other events Mar 20, 2026 8-K Change in control; Amended charter or bylaws; Regulation FD disclosure; Other events Feb 24, 2026 10-Q Quarter ended 2025-09-30 Jan 13, 2026 8-K Director or officer change; Other events Nov 14, 2025 8-K Director or officer change Oct 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Changed accountants Aug 13, 2025 8-K Director or officer change; Other events Jun 24, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Other events May 2, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Apr 29, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 28, 2025 8-K Results of operations (earnings release) Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Regulation FD disclosure Mar 19, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 7, 2025 8-K Delisting notice or listing-rule failure Feb 18, 2025 8-K Regulation FD disclosure Jan 10, 2025 8-K Regulation FD disclosure Dec 19, 2024 8-K Delisting notice or listing-rule failure; Director or officer change; Shareholder vote results Dec 13, 2024 8-K Regulation FD disclosure Dec 12, 2024 8-K Other events Nov 25, 2024 8-K Results of operations (earnings release) Nov 15, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Oct 11, 2024 8-K Delisting notice or listing-rule failure Sep 13, 2024 8-K Regulation FD disclosure Aug 21, 2024 8-K Results of operations (earnings release) Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events Jul 11, 2024 8-K Other events Jun 14, 2024 8-K Regulation FD disclosure Jun 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 5, 2024 8-K Other events Jun 3, 2024 8-K Regulation FD disclosure May 30, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024